Cancer screening of long-term cancer survivors.

Cancer screening of long-term cancer survivors.
复制标题

DOI:
10.3122/jabfm.2012.04.110118
复制
发表时间:
2012-07
期刊:
Journal of the American Board of Family Medicine : JABFM
影响因子:
--
通讯作者:
Smith MA
Smith MA
中科院分区:
其他
文献类型:
--
作者:
Schumacher JR;Witt WP;Palta M;Loconte NK;Heidrich SM;Trentham-Dietz A;Pandhi N;Smith MA

文献摘要

参考文献

被引文献

相似文献

虽然64%的癌症幸存者预计在诊断后至少能活五年,但这一人群接受癌症筛查的情况尚不清楚。该研究的目的是评估癌症诊断和未来癌症筛查之间的关系,探索解释观察到的关系的提供者,患者和癌症特异性因素。威斯康星州纵向研究(WLS)和威斯康星州肿瘤登记处用于确定两个参与者组:415名在1992-1993年(癌前)和2003-2004年(癌后)之间诊断为非转移性癌症的患者和4,680名非癌症对照组。调整后的平均预测癌症筛查概率估计模型,首先不包括,然后包括,供应商(供应商关系长度),参与者(抑郁症状(CES-D))和癌症特异性(自诊断以来的时间)因素。然后排除与给定筛选测试相关的癌症病史的参与者,以评估是否通过筛选复发与第二种癌症来解释关系。女性癌症幸存者比非癌症对照组更有可能接受盆腔/pap(70%,95%置信区间(CI)=63-76%和61%,CI =59-63%)和乳腺X线筛查(86%,CI =78-90%和76%,CI =74-77%),但男性癌症幸存者接受前列腺检查的可能性并不高(76%,CI =70-82%和69%,CI =67-71%)。在排除了有癌症筛查史的人之后,短期或长期幸存者(>5年)与无癌症对照之间的癌症筛查几乎没有显着差异。关系是不敏感的供应商或参与者因素的调整。癌症患者和非癌症患者之间癌症筛查的显著积极差异可以通过筛查复发来解释。长期癌症幸存者不太可能接受第二次癌症的后续筛查。提供者应使用这些信息,以确保患者接受推荐的后续预防性护理。
Although 64% of cancer survivors are expected to live at least five years beyond diagnosis, the receipt of cancer screening by this population is unclear. The study objective is to assess the relation between a cancer diagnosis and future cancer screening, exploring provider, patient, and cancer-specific factors that explain observed relationships. The Wisconsin Longitudinal Study (WLS) and Wisconsin Tumor Registry were used to identify two participant groups: 415 diagnosed with non-metastatic cancer between 1992-1993 (pre-cancer) and 2003-2004 (post-cancer) and 4,680 no-cancer controls. Adjusted average predicted probabilities of cancer screening were estimated with models that first did not include and then included, provider (provider relationship length), participant (depressive symptoms (CES-D)) and cancer-specific (time since diagnosis) factors. Participants with a history of the cancer associated with a given screening test were then excluded to assess whether relationships are explained by screening for recurrence versus second cancers. Female cancer survivors were more likely than no-cancer controls to undergo pelvic/pap (70%, 95% confidence interval (CI)=63-76% and 61%,CI=59-63%) and mammography screening (86%,CI=78-90% and 76%,CI=74-77%), though male cancer survivors were not more likely to receive prostate exams (76%,CI=70-82% and 69%,CI=67-71%). After excluding people with a history of the cancer being screened for, there were few significant differences in cancer screening between short or long-term survivors (>5 years) and no-cancer controls. Relationships were not sensitive to adjustment for provider or participant factors. The significant positive differences in cancer screening between people with and without cancer can be explained by screening for recurrence. Long-term cancer survivors are not more likely to receive follow-up screening for second cancers. This information should be used by providers to ensure patients receive recommended follow-up preventive care.
DOI: 10.4278/0890-1171-15.1.29
发表时间: 2000-09-01
影响因子: 2.7
作者:
Green, CA;Pope, CR
通讯作者: Pope, CR
DOI: 10.1200/jco.2008.18.0679
发表时间: 2009-02-20
影响因子: 45.3
作者:
Mao, Jun J.;Bowman, Marjorie A.;Armstrong, Katrina
通讯作者: Armstrong, Katrina
DOI: 10.1007/s11764-008-0058-x
发表时间: 2008-09-01
期刊: Journal of cancer survivorship : research and practice
影响因子: --
作者:
Bloom, Joan R;Stewart, Susan L;Banks, Priscilla J
通讯作者: Banks, Priscilla J
DOI: 10.1200/jco.2005.02.2343
发表时间: 2005-12-01
影响因子: 45.3
作者:
Bellizzi, KM;Rowland, JH;McNeel, T
通讯作者: McNeel, T
DOI: 10.2307/2137284
发表时间: 1995-03-01
影响因子: 5
作者:
ANDERSEN, RM
通讯作者: ANDERSEN, RM